ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 116 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,533,000 | -79.3% | 800,700 | -73.5% | 0.02% | -77.6% |
| Q2 2015 | $26,743,000 | -4.6% | 3,018,430 | +6.2% | 0.07% | -1.5% |
| Q1 2015 | $28,036,000 | +39.3% | 2,843,430 | +73.0% | 0.07% | +38.8% |
| Q4 2014 | $20,132,000 | +603.4% | 1,643,430 | +88.9% | 0.05% | +512.5% |
| Q1 2014 | $2,862,000 | +50.9% | 870,009 | +38.5% | 0.01% | +60.0% |
| Q3 2013 | $1,897,000 | -83.6% | 628,267 | -55.6% | 0.01% | -86.1% |
| Q2 2013 | $11,579,000 | +4.0% | 1,415,467 | +11.3% | 0.04% | -2.7% |
| Q1 2013 | $11,131,000 | – | 1,272,067 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |